Tyrosine Kinase Inhibitor Cabozantinib Inhibits Murine Renal Cancer by Activating Innate and Adaptive Immunity

JOURNAL ARTICLE published 19 April 2021 in Frontiers in Oncology

Authors: Hongyan Liu | Shishuo Sun | Gang Wang | Mengmeng Lu | Xiaokang Zhang | Xiaohuan Wei | Xiaoge Gao | Chao Huang | Zhen Li | Junnian Zheng | Qing Zhang